Samrat Pharmachem Ltd

NSE: BSE: 530125

₹211.80

(1.36%)

Sat, 28 Mar 2026, 07:16 am

MTF 5xInvest in Samrat Pharmachem Ltd with 5x Leverage Buy with MTF

Market Cap654.4M

PE Ratio0

Dividend0.47

Process Industries

Chemicals: Specialty

24.5K

Samrat Pharmachem Return on Equity (ROE) History

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	0	3.84	4.21	2.46	16.15	25.90	36.08	27.50	13.91	12.15	15.02	4.37	7.88	8.72	6.89	47.64	13.59
Price to book ratio	0.39	0.59	0.65	0.74	0.50	0.48	0.85	0.61	1.59	2.11	1.15	0.76	1.42	3.20	1.82	1.59	1.35
Price to sales ratio	0.07	0.10	0.13	0.13	0.09	0.10	0.24	0.13	0.34	0.42	0.21	0.13	0.23	0.68	0.37	0.37	0.34
Price to cash flow ratio	5.78	4.71	0	2.34	0	1.53	0	6.43	0	0	16.28	0	11.56	8.84	0	11.34	0
Enterprise value	18.73M	29.13M	57.75M	82.57M	82.3M	50.26M	106.8M	83.89M	241.88M	444.92M	273.5M	267.43M	482.7M	1.43B	1.21B	1.02B	1.06B
Enterprise value to EBITDA ratio	4.22	1.51	2.40	1.38	7.63	8.35	9.13	7	6.54	7.57	8.67	4.06	5.40	5.85	5.02	36.10	9.94
Debt to equity ratio	0.38	0.22	0.22	0.27	0.35	0.24	0.24	0.40	0.45	0.51	0.33	0.39	0.30	0.16	0.30	0.13	0.14
Return on equity %	0	16.54	16.68	35.61	3.15	1.86	2.38	2.21	12.07	19	7.96	19.10	19.77	44.95	30.25	3.38	10.40

Samrat Pharmachem Ltd Return on Equity

The Samrat Pharmachem Ltd Return on Equity is a key financial metric used by investors to evaluate Samrat Pharmachem Ltd's valuation, profitability, and overall financial performance. Tracking the Samrat Pharmachem Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Samrat Pharmachem Ltd (NSE: , BSE: 530125) is currently trading at ₹211.80, with a market capitalization of ₹654.4M. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Samrat Pharmachem Ltd Return on Equity is essential for fundamental analysis.

Samrat Pharmachem Ltd Return on Equity Current Value

The current Samrat Pharmachem Ltd Return on Equity stands at 10.40.

The latest Samrat Pharmachem Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Samrat Pharmachem Ltd Return on Equity Historical Trend

The Samrat Pharmachem Ltd Return on Equity has shown the following historical trend:

2024: 10.40
2023: 3.38
2022: 30.25
2021: 44.95
2020: 19.77

The recent rise in Samrat Pharmachem Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.

What Samrat Pharmachem Ltd Return on Equity Indicates for Investors

The Samrat Pharmachem Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Samrat Pharmachem Ltd Return on Equity Analysis Summary

The Samrat Pharmachem Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Samrat Pharmachem Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Samrat Pharmachem Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800